Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
公司代碼AMIX
公司Autonomix Medical Inc
CEOHauser (Bradley)
網址https://autonomix.com/
常見問題
Autonomix Medical Inc(AMIX)的當前股價是多少?
Autonomix Medical Inc(AMIX)的當前股價是 0.598。
Autonomix Medical Inc 的股票代碼是什麼?
Autonomix Medical Inc的股票代碼是AMIX。
Autonomix Medical Inc股票的52週最高點是多少?
Autonomix Medical Inc股票的52週最高點是4.580。
Autonomix Medical Inc股票的52週最低點是多少?
Autonomix Medical Inc股票的52週最低點是0.590。
Autonomix Medical Inc的市值是多少?
Autonomix Medical Inc的市值是3.71M。
Autonomix Medical Inc的淨利潤是多少?
Autonomix Medical Inc的淨利潤為-11.41M。
現在Autonomix Medical Inc(AMIX)的股票是買入、持有還是賣出?
根據分析師評級,Autonomix Medical Inc(AMIX)的總體評級為--,目標價格為--。
Autonomix Medical Inc(AMIX)股票的每股收益(EPS TTM)是多少
Autonomix Medical Inc(AMIX)股票的每股收益(EPS TTM)是-3.704。